[HTML][HTML] Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

HC Sun, J Zhou, Z Wang, X Liu, Q Xie… - … surgery and nutrition, 2022 - ncbi.nlm.nih.gov
Recent advances in systemic and locoregional treatments for patients with unresectable or
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …

Regulation of liver regeneration by growth factors and cytokines

F Böhm, UA Köhler, T Speicher… - EMBO molecular …, 2010 - embopress.org
The capability of the liver to fully regenerate after injury is a unique phenomenon essential
for the maintenance of its important functions in the control of metabolism and xenobiotic …

Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases

J Shindoh, CWD Tzeng, TA Aloia, SA Curley… - Annals of surgical …, 2013 - Springer
Background Patients with colorectal liver metastases (CLM) are increasingly treated with
preoperative chemotherapy. Chemotherapy associated liver injury is associated with …

Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases

Z Dexiang, R Li, W Ye, W Haifu, Z Yunshi… - Annals of surgical …, 2012 - Springer
Objective This study was designed to evaluate the long-time outcome of patients with
colorectal liver metastasis (CRLM) undergoing different types of therapy and identify …

Update on the role of imaging in management of metastatic colorectal cancer

SH Tirumani, KW Kim, M Nishino, SA Howard… - Radiographics, 2014 - pubs.rsna.org
Evolution in the treatment of metastatic colorectal cancer (mCRC) has led to significant
improvement in the survival of these patients. Surgery is useful in patients with resectable …

[HTML][HTML] Treatment of colorectal liver metastases

N Ismaili - World Journal of Surgical Oncology, 2011 - Springer
Colorectal cancer (CRC) is the third most common cancer in the word. Liver metastasis is
the most common site of colorectal metastases. The prognosis of resectable colorectal liver …

Pharmacometabolomics reveals irinotecan mechanism of action in cancer patients

X Bao, J Wu, S Kim, P LoRusso… - The Journal of Clinical …, 2019 - Wiley Online Library
The purpose of this study was to identify early circulating metabolite changes implicated in
the mechanism of action of irinotecan, a DNA topoisomerase I inhibitor, in cancer patients. A …

Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience

PS Wolf, JO Park, F Bao, PJ Allen, RP DeMatteo… - Journal of the American …, 2013 - Elsevier
BACKGROUND: Patients undergoing liver resection for colorectal cancer liver metastasis
(CRCLM) are often treated with chemotherapy before surgery. However, the associations …

Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12

Q Xu, L Guo, X Gu, B Zhang, X Hu, J Zhang, J Chen… - Biomaterials, 2012 - Elsevier
The development of effective therapies for the prevention of colorectal cancer (CRC) liver
metastasis is of great importance. Recently, chitosan (CS) nanoparticles have been utilized …

[HTML][HTML] A synthetic biology-based device prevents liver injury in mice

P Bai, H Ye, M Xie, P Saxena, H Zulewski… - Journal of …, 2016 - Elsevier
Background & Aims The liver performs a panoply of complex activities coordinating
metabolic, immunologic and detoxification processes. Despite the liver's robustness and …